Pediatric Neurology Fellow - FAST Fellowships in Angelman Syndrome and Neurogenetic Diseases

The Department of Pediatrics at Rush University Medical Center is recruiting two candidates for a Fellowship in Clinical Trials for Innovative Therapeutics in Angelman syndrome and other Neurogenetic Disorders to join the Department of Pediatrics, Division of Pediatric Neurology for a one-year fellowship in translational neuroscience.

We welcome both domestic and international candidates to apply. This is a unique opportunity for qualified individuals to further develop their translational and clinical research training at a leading academic medical center, conducting this work with mentorship in cutting-edge research using mechanism-targeted treatment for Angelman syndrome and other rare monogenic NDDs.

This one-year fellowship opportunity is for physicians to be mentored in the translational neuroscience program headed by Elizabeth Berry-Kravis, MD, PhD.

As the leading investigator in multiple NIH-funded research programs and industry-and foundation-sponsored clinical trials, Dr.

Berry-Kravis has established Rush University Medical Center as an international destination for rare disease treatment and research in the area of pediatric neurodevelopmental and neurogenetic conditions.

During the one-year fellowship, the fellow will learn about clinical trial design, including novel clinical trials for rare genetic pediatric NDDs including N-of-1 trials, development of specialized programs for clinical management of these conditions with accommodation of experimental treatments, and new outcome measure and biomarker development for these populations.

The fellowship will include time in clinic, however the majority of time will be spent working and training on translational and clinical research.

The successful candidate will have recently completed fellowship in Child Neurology (preferred), Child Psychiatry or Developmental Behavioral Pediatrics, and will have an interest in starting a career in translational neuroscience for neurodevelopmental disorders.

Interested candidates, please send your CV and cover letter to :

Alyssa Taylor,

Recruiter, Department of Provider & Faculty Recruitment

The Foundation for Angelman Syndrome Therapeutics (FAST), is the primary patient advocacy organization devoted to a cure for Angelman Syndrome.

As the largest non-governmental funder of AS research, FAST sets the agenda for the entire drug development ecosystem for this rare disease.

Our goal is to bring transformative treatments into current medical practice as quickly and safely as possible, in order to ensure that individuals living with Angelman syndrome are able to reach their full potential and quality of life as soon as humanly possible.

This fellowship is funded as part of the new Center for clinical trials and translational research efforts underway for rare neurodevelopmental disorders.

Rush University Medical Center has received Vizient's Quality Leadership Award, ranking first among 99 academic medical centers across the country.

All three Rush University System for Health hospitals have earned the LGBTQ Healthcare Equality Leader designation in the Healthcare Equality Index.

Rush is an equal opportunity / Affirmative Action employer